On the evening of November 8, a number of listed companies in Shanghai and Shenzhen stock exchanges issued announcements. The following is a summary of important announcements.
[Definite increase in mergers and acquisitions]
Saiteng shares: plans to acquire 210 million yuan to acquire Lingou Technology
Saiteng shares announced that the company intends to issueConvertible bond, shares and payment of cash, purchase 100% equity of Lingou Technology, the transaction price of 210 million yuan. Among them, 60% of the transaction consideration is paid by issuing convertible bonds. At the same time, the company plans to raise funds of no more than 140 million yuan. Lingou Technology is an automation equipment manufacturer, and the counterparty promises that Lingou Technology will not lower the net profit of RMB 20 million, RMB 17 million and RMB 21 million respectively from 2018 to 2020.
Hengkang Medical: termination of planning for major asset restructuring
Hengkang Medical announced that the company originally planned to use cash to purchase 93.52% of the shares of Maanshan Central Hospital Co., Ltd. In order to ensure the stable operation and long-term healthy development of the company, the board of directors of the company decided to terminate the acquisition of Maanshan Hospital. Due to the company's own reasons to terminate the acquisition, Maanshan Hospital shareholders will not refund the company's 20 million yuan of earnest money.
HNA Holdings: Termination of the purchase of HNA Group's 10 billion assets
HNA Holdings announced that in view of the current macroeconomic environment changes and fluctuations in the domestic securities market, the company is continuing to push forward major asset restructurings. The company intends to terminate the major asset restructuring and will hold an investor statement on November 21. meeting. According to the restructuring plan disclosed earlier, the company plans to issue shares to purchase the Hundreds of Billion assets of HNA Group and raise 7 billion matching funds.
Aoma Electric: Shareholders intend to reduce their holdings by no more than 1%
Omar Electric announced that the company's 7.63% shareholder Cai Zheyi plans to reduce the company's shares by no more than 1%, ie, no more than 10.84 million shares, within three months after 15 trading days.
Zhuhai Zhongfu: won the first line of the new Silk Road
Zhuhai Zhongfu announced that Shaanxi Xinsi Road Progressive Investment Partnership (Limited Partnership) increased its shareholding in Zhuhai Zhongfu by 64,285,151 shares through the Shenzhen Stock Exchange's centralized bidding trading system from October 17 to November 7, 2018. 5.00% of the total.
CICC Environment: The controlling shareholder intends to transfer the shares of Wuxi Municipal Government or the company's actual controller
CICC Environmental Announcement, the company's controlling shareholder, real controller Shen Jinhao and shareholder Shen Jieyong, signed an interest transfer agreement with Wuxi Municipal Public Utilities Group Co., Ltd. (referred to as “Wuxi Municipal”), intending to separate the company 6.65%, 2.13 % of the shares were transferred to Wuxi Municipal. If the equity transfer plan is approved by the state-owned assets supervision department, Shen Jinhao intends to permanently entrust the Wuxi municipal government with the voting rights of another 192 million shares. If the formal agreement is finally signed, the controlling shareholder and actual controller of the company will be changed to Wuxi Municipal. The company's stock will be suspended from November 9.
Kaizhong shares: Julei Investment intends to reduce its holdings by no more than 2%
Kaizhong shares announced that Julei Investment plans to reduce the company's shares by 2,180,500 shares within 6 months through centralized bidding, that is, not exceeding 2% of the total share capital. Julei Investment currently holds 3.94%.
Financial Street: Some Dong Jiangao 7 Sunrise Handheld
Financial Street Announcement, in order to convey the confidence of the company's directors and supervisors and senior management on the company's business development, on November 7, some of the company's directors and supervisors increased their shareholdings through centralized bidding transactions, adding a total of 270,000 shares. In addition, the company's wholly-owned subsidiary recently won the use of state-owned land in Wentou Ridge, Huidong District, Huizhou City for a total area of 91,000 square meters with 1.709 billion yuan.
Tailong Pharmaceutical: plans to buy back 20 million to 250 million yuan
Tailong Pharmaceutical disclosed the repurchase plan. The total amount of repurchase planned by the company was 20 million to 250 million yuan, and the repurchase price did not exceed 5 yuan/share.
Fuxiang shares: The director proposed that the company repurchase shares from 100 million to 200 million yuan
Fuxiang shares announced that Xu Chunxia, director and financial controller of the company, proposed that the company repurchase some social public shares through centralized trading. The repurchase amount is 100 million yuan to 200 million yuan, and the repurchase price does not exceed 20 yuan/share.
Huasi Shares: Proposed to buy back shares of 50 million to 100 million yuan
Huasi shares disclosed the repurchase plan. The company plans to repurchase shares no less than 50 million yuan and no more than 100 million yuan. The repurchase price does not exceed 10 yuan/share.
Kaier New Materials: Proposed to buy back shares of 50 million to 100 million yuan
Kaier New Materials disclosed the repurchase plan, the company plans to not less than 50 million yuan, and no more than 100 million yuan to buy back shares, the repurchase price does not exceed 8.5 yuan / share.
Sanquan Food: The maximum amount of shares repurchased is adjusted to 100 million yuan
Sanquan Food announced that the company intends to modify the repurchase share plan, the original planned repurchase amount is 50 million yuan to 200 million yuan; after the revision, it is planned to buy back 50 million yuan to 100 million yuan. The repurchase price limit is still 8 yuan / share.
Zhengye Technology: The controlling shareholder and the actual controller are rescued by the Dongguan bailout fund
Zhengye Technology Announcement, Xu Dihua, one of the controlling shareholders of the company, and one of the actual controllers, signed the “Investment and Financing Cooperation Agreement” with the listed Dongguan Enterprise Development Investment Partnership. The listed investment in Dongguan Enterprise is intended to be provided to Zhengye Industry and Xu Dihua. Investment and financing funds support, and agreed to provide the first batch of support funds of not less than 400 million yuan before November 12. It is reported that the development of listed enterprises in Dongguan is a fund mainly set up by the government for Dongguan listed companies, aiming at alleviating the liquidity of listed companies. Among the five partners of the fund, Dongguan Financial Holdings and Songshan Lake Holdings are two state-owned enterprises.
BOE A: Planning to build a life science and technology industrial base in Beijing, the total investment of the first phase is 13.6 billion
BOE A announced that the company signed a project cooperation agreement with the Beijing Fangshan District Government. The two parties intend to jointly build the Beijing BOE Life Technology Industrial Base project in Beijing's high-end manufacturing base. The project will be implemented in two phases: the first phase of the layout includes the R&D and operation center of the Health Business Headquarters, the Life Science and Technology Innovation Center/International Medical Transformation Center and the Center for Excellence in Medicine, and the Digital Hospital (Phase I). The total investment is about 13.6 billion yuan. It was put into operation in 2022; the second phase of the plan includes Digital Hospital (Phase II), Global Partner Industrial Park and other projects.
Liuguo Chemical: Director Ma Suan accepts disciplinary review and supervision investigation and resigns
Liuguo Chemical announced that Ma’an, the former party secretary of Tongling Chemical Group and the current director of the company, was suspected of serious violation of discipline and law. He is currently undergoing disciplinary review and supervision investigation. The company received a written resignation report from Masuan on the same day. This matter will not affect the company's production and operation.
Siyuan Electric: won the bid of 491 million yuan National Grid Project
Siyuan Electric announced that the company and its subsidiaries won the bid for the national grid related projects. According to the announcement of the bid, the company and its subsidiaries won the bid in 24 provinces (regions) such as Jiangsu, Zhejiang and Shandong. The winning products include combination electric appliances, reactors, transformers and capacitors. The total bid amount is about 491 million yuan.
Guiyang Bank: Li Zhongxiang resigned due to work transfer
Guiyang Bank announced that Li Zhongxiang, the company's director and president, submitted a resignation report to the company's board of directors on the same day due to work transfer. Li Zhongxiang’s resignation took effect on November 8.
WuXi PharmaTech: The issuance of H shares was approved by the China Securities Regulatory Commission
WuXi PharmaTech announced that the company has received approval from the China Securities Regulatory Commission to approve the company's new issue of no more than 211 million overseas listed foreign shares, with a par value of RMB 1 per share, all of which are common shares. Upon completion of the issuance, the company can be listed on the main board of the Hong Kong Stock Exchange. The issuance and listing of overseas listed foreign shares still needs final approval from the Hong Kong Stock Exchange, and there is still uncertainty.
Zhongdi Investment: plans to sell a property in Chaoyang District, Beijing for 13.5 million yuan
Zhongdi Investment announced that in order to revitalize the idle assets, the company will sell the property (the construction area of 193.93 square meters) of Unit 2, 25, 25th Floor, No. 1 Dongfang East Road, Chaoyang District, Beijing, to Tianli Tianli Company at a price of 13.5 million yuan. The transaction is expected to generate a pre-tax income of approximately $7.43 million.
Hengtai Aipu: Zhongguancun M&A mother fund 420 million shares in the new Jinhua machine
Hengtai Aip announced that Zhongguancun M&A Fund intends to invest 420 million yuan to purchase 35% of the company's subsidiary Xinjinhua. After the transaction, the company holds 62.89% of the shares of Xinjinhua, and remains the largest shareholder and actual controller of Xinjinhua. The equity transfer of Xinjinhua Machine is to introduce strategic investors, enhance the financial strength, accelerate the development of the company's high-end industrial steam turbines and centrifugal compressors, as well as the core technology products of gas turbines.
Huiyuan Communication: Shareholder Shanghai Leyi and concerted action person Anhui Hongxu were ordered to correct
Huiyuan Communications announced that the Sichuan Securities Regulatory Bureau issued a notice and decided to take corrective measures against the company's shareholder Shanghai Leyi and its concerted action, Anhui Hongxu, because the two companies were unfairly treated in the process of acquiring some shares of Huiyuan Communications. Shareholders, failure to disclose progress announcements and other violations as required. At the same time, the Sichuan Securities Regulatory Bureau issued a warning letter to Shanghai Leyi because of its existence in the absence of timely disclosure of the pledge of the shares.
Jincheng Medicine: Subsidiary obtained GMP certificate for drugs
Jincheng Pharmaceutical announced that Shandong Jincheng Biological Pharmaceutical Co., Ltd., a subsidiary of the company, received the “Drug GMP Certificate” issued by Shandong Food and Drug Administration on November 7, 2018. The scope of certification: raw material medicine (glutathione, Second workshop A-05-01 production line), valid until October 24, 2023.
China Resources Shuanghe: Subsidiary China Resources SECCO passed FDA on-site inspection
China Resources Shuanghe announced that China Resources Secco, a wholly-owned subsidiary of the company, recently received a “zero defect” on-site inspection report issued by the US Food and Drug Administration (“FDA”), indicating that China Resources Secco meets the requirements of the US drug cGMP quality system. Passed the FDA on-site inspection. The on-site inspection by the FDA is the production workshop of Oral Secco Oral Solid Preparation.
Guanghui Auto: Liu Ruiguang as Vice President Once served as General Manager of the Business Group of Evergrande Real Estate
Guanghui Auto announced that the company's board of directors hired Liu Ruiguang as the company's vice president. Liu Ruiguang was the deputy general manager of Evergrande Sichuan Company and the general manager of the business group of Evergrande Real Estate Group. Guanghui Auto previously announced that Evergrande's shareholding in Guanghui Group has been completed and will accelerate the follow-up cooperation.
Dabei Nong: Incentive Financing Service of Hua Xia Bank Beijing Branch
Dabei Agricultural announced that the company signed a bank-enterprise cooperation agreement with Huaxia Bank Beijing Branch. Huaxia Bank Beijing Branch provides the intentional financing service with a cooperation amount of not more than 2 billion yuan. The two sides will strengthen cooperation in the field of investment and financing, support the company's development and prevent and resolve financial risks, and jointly explore diversified investment and financing methods, and improve the investment and financing system.
Lubei Chemical: Some investors apply to participate in the company's controlling shareholder mixed reform
Lubei Chemical announced that Lubei Group, the controlling shareholder of the company, has adopted the public listing and collection procedures to carry out mixed ownership reform through capital increase and share expansion. As of the expiration of the listing period, one intent to submit an investment application, the Shandong Property Rights Exchange Center intends to adopt an agreement to transfer the transaction. There are still uncertainties in the transaction, such as the review of the intentional investor qualification review and the signing of the capital increase agreement.
Zhenhai shares: signed a contract of 277 million yuan
Zhenhai Co., Ltd. announced that the company has recently received the contract signed and sealed by Sinochem Quanzhou Petrochemical Co., Ltd., “Sinochem Quanzhou 1 million tons/year ethylene and oil refining expansion and expansion project, polyolefin finished packaging and three-dimensional warehouse EPC general contracting project contract”, tentatively The total price is 276.98 million yuan (including tax).
Jiangsu Wuzhong: Subordinate companies obtained 2 drug registration approvals
Jiangsu Wuzhong announced that the company's Suzhou pharmaceutical factory recently received two "drug registration approvals", the names of the drugs are vinpocetine injection, potassium aspartate injection. Suzhou Pharmaceutical Factory will start work related to the production of pharmaceuticals.
Huaxia Happiness: In October, it cost 543 million yuan to acquire land.
Huaxia Happiness announced that the company and its subsidiaries had a total land area of 54,900 square meters in October, with a total turnover of 543 million yuan. The land they were competing was located in Hebei Dachang, Zhejiang Jiashan and Sichuan Pujiang. In addition, the company was confirmed as the transaction social capital of the PPP project of Heshang Industrial New Town, Xiaoshan District, Hangzhou City, Zhejiang Province.
Luxi Chemical: Trial operation of the second phase of the polycarbonate project
Luxi Chemical announced that the production process of the second phase of the company's polycarbonate project has been opened in the near future. The trial operation is progressing smoothly, the operation load reaches the design capability, and the product quality is excellent. At present, we are formulating a plan to eliminate bottlenecks and re-optimize, and strive to break through in terms of output and quality.
Jiaying Pharmaceutical: Received a warning letter from Guangdong Securities Regulatory Bureau
Jiaying Pharmaceutical announced that it violated the letter-sharing regulations due to the significant difference between the company's 2017 annual performance forecast announcement announcement and the net profit disclosed in the performance report and the 2017 audited net profit. The Guangdong Securities Regulatory Bureau decided to issue a warning letter to Chen Yonghong, the then chairman of the company, and Huang Libing, the general manager of the company, and Chen Xiaoyan, the chief financial officer.
Beibu Gulf Port: cargo throughput increased by 25.41% year-on-year in October
Beibu Gulf Port announced that in October, the company's cargo throughput was 1,753.11 million tons, a year-on-year increase of 25.41%; the cumulative cargo throughput in January-October was 152,384,500 tons, an increase of 14.92%.
Deep Chiwan A: cargo throughput in the first 10 months decreased by 4.8% year-on-year
Deep Chiwan A announced that by the end of October 2018, the company had completed a total cargo throughput of 55.837 million tons, a decrease of 4.8% over the same period last year. Among them, the container throughput totaled 4.442 million TEU (standard box), an increase of 1.7% over the same period of last year; the bulk cargo throughput totaled 17.247 million tons, a decrease of 4.5% over the same period last year.
Oriental Garden: “17 Oriental Garden CP001” has been paid on schedule.
Oriental Garden announced that the company's first short-term financing bill in 2017 (17 Oriental Garden CP001) has been paid on time, with a total principal and interest of 1,054.5 million yuan. The company's current capital position is good and its operating conditions are normal.
Renren: The controlling shareholder intends to issue exchangeable bonds
Renren Music announced that Haoming Investment, the controlling shareholder of the company, intends to issue non-public issuance of exchangeable bonds based on part of the shares held by the company. The proposed issuance period is not more than three years, and the proposed fundraising scale does not exceed 330 million yuan. Haoming Investment currently holds 193 million shares of the company, accounting for 48.22% of the total share capital.